COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,673 Articles (22,913 medRxiv, 8,760 bioRxiv)

Most recent first Previous |  Page 522: Articles 5211-5220  | Next

A comprehensive survey on the beliefs, perceptions, and clinical manifestations of pre and post Covid-19 vaccinations among physiotherapy students in the United Arab Emirates
AlMheiri, S., Hazari, A., Kumar, P., Kumar, S., Girish, S.
10.1101/2023.02.17.23285959 — Posted: 2023-02-23
Prevalence of smell, taste and chemesthesis disorders among patients with the Omicron Variant of SARS-CoV-2 in China
Chen, Y., Chen, Y., Liu, X., Yan, C., Zou, L.
10.1101/2023.02.21.23286242 — Posted: 2023-02-23
Immune response to SARS-CoV-2 mRNA vaccination in multiple sclerosis patients after rituximab treatment interruption
Groning, R., Dernstedt, A., Ahlm, C., Normark, J., Sundstrom, P., Forsell, M. N.
10.1101/2023.02.21.23286229 — Posted: 2023-02-23
Broadly effective ACE2 decoy proteins protect mice from lethal SARS-CoV-2 infection
Lu, M., Yao, W., Li, Y., Ma, D., Zhang, Z., Wang, H., Tang, X., Wang, Y., Li, C., Cheng, D., Lin, H., Yin, Y., Zhao, J., Zhong, G.
10.1101/2023.02.22.529625 — Posted: 2023-02-23
Analysis of the SARS-CoV-2 spike protein revealed that blocked receptor-binding domain antigenicity decreases the production of neutralizing antibodies in vivo
Mei, Y.-F., Zhang, Q., Hammond, M. E., Song, J., Fang, Z., Zhao, H., Landstrom, M.
10.1101/2023.02.23.529497 — Posted: 2023-02-23
Characteristics and Outcomes of Multisystem Inflammatory Syndrome in Children: A Multicenter, Retrospective, Observational Cohort Study in Mexico
Gonzalez-Garcia, N., Yamazaki-Nakashimada, M. A., Marquez-Gonzalez, H., Miranda-Novales, G., Neme Diaz, G. A., Prado Duran, S. A., Luevanos Velazquez, A., CASTILLA PEON, M. F., Sanchez Duran, M. A., Marquez Aguirre, M. P., Villasis-Keever, M. A., Aragon Nogales, R., Nunez Enriquez, C., Martinez Bustamante, M. E., Palacios Cantu, L. A., Membrila Mondragon, J., Vizcarra Alvarado, P., Jimenez Juarez, R. N., Olivar Lopez, V., Lopez Chavez, A., Perez Barrera, A., Aguilar Arguello, C., Ramirez de los Santos, J.
10.1101/2023.02.16.23285979 — Posted: 2023-02-23
SARS-CoV2 mRNA-vaccination-induced Immunological Memory in Human Non-Lymphoid and Lymphoid Tissues
Pross, V., Sattler, A., Lukassen, S., Toth, L., Thole, L. M. L., Siegle, J., Stahl, C., He, A., Damm, G., Seehofer, D., Goetz, C., Bayerl, C., Jaeger, P., Macke, A., Eggeling, S., Kirzinger, B., Mayr, T., Herbst, H., Bayer, K., Laue, D., Kroenke, J., Braune, J., Rosseck, F., Friedersdorff, F., Hubatsch, M., Weinberger, S., Lachmann, N., Hofmann, V., Schrezenmeier, E., Ludwig, C., Schrezenmeier, H., Jechow, K., Conrad, C., Kotsch, K.
10.1101/2023.02.22.23286293 — Posted: 2023-02-23
Rapid emergence of transmissible SARS-CoV-2 variants in mild community cases
Crone, M. A., Hakki, S., Zhou, J., Rosadas de Oliveira, C., Madon, K. J., Koycheva, A. V., Badhan, A., Jonnerby, J., Fenn, J., Kundu, R., Barnett, J. L., Nevin, S., Conibear, E., Derqui-Fernandez, N., Pillay, T. D., Varro, R., Luca, C., Quinn, V., Shazaad, A., Zambon, M., Barclay, W., Dunning, J., Freemont, P. S., Taylor, G. P., Lalvani, A.
10.1101/2023.02.15.23285923 — Posted: 2023-02-23
Excess burden of respiratory and abdominal conditions following COVID-19 infections during the ancestral and Delta variant periods in the United States: An EHR-based cohort study from the RECOVER Program
Varma, J. K., Zang, C., Carton, T. W., Block, J. P., Khullar, D. J., Zhang, Y., Weiner, M. G., Rothman, R. L., Schenck, E. J., Xu, Z., Lyman, K., Bian, J., Shenkman, E., Maughan, C., Castro-Baucom, L., OBrien, L., Wang, F., Kaushal, R.
10.1101/2023.02.15.23286012 — Posted: 2023-02-23
BRIEF COMMUNICATION High level of Anti SARS-Co-V2 RBD Antibody one year post booster vaccine hospital workers in Indonesia; Was second booster needed?
Muslimah, A. H., Tiara, M. R., Djauhari, H., Dewantara, H., Susandi, E., Indrati, A. R., Soeroto, A. Y., Alisjahbana, B., Wisaksana, R.
10.1101/2023.02.15.23285958 — Posted: 2023-02-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).